Immunochemistry Analyzers Devices Pipeline Assessment, 2019 Report - ResearchAndMarkets.com

DUBLIN--()--The "Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

Scope

  • Extensive coverage of the Immunochemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 List of Tables & Figures

2 Introduction

2.1 Immunochemistry Analyzers Overview

3 Products under Development

3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development

3.2 Immunochemistry Analyzers - Pipeline Products by Segment

3.3 Immunochemistry Analyzers - Pipeline Products by Territory

3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path

3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date

3.6 Immunochemistry Analyzers - Ongoing Clinical Trials

4 Immunochemistry Analyzers - Pipeline Products under Development by Companies

4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development

4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development

5 Immunochemistry Analyzers Companies and Product Overview

6 Immunochemistry Analyzers- Recent Developments

6.1 Nov 12, 2019: New breakthrough in Lyme Disease testing reduces time to results from days to minutes

6.2 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights

6.3 Nov 06, 2019: Meridian submits Curian analyzer and the Curian HpSA assay to the FDA

6.4 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results

6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019

6.6 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI

6.7 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance

6.8 Oct 31, 2019: BioTek launches a set of quantitative assay apps to simplify detection-based applications

6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results

6.10 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results.

6.11 Oct 31, 2019: SDI Group: Change of name

6.12 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance

6.13 Oct 30, 2019: Quidel reports third quarter 2019 financial results

6.14 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results

6.15 Oct 30, 2019: Tecan appoints Ralf Griebel a member of the Management Board and Head of Partnering Business

6.16 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019

7 Appendix

Companies Mentioned

  • Access Bio Inc
  • ADOR Diagnostics Ltd
  • AgPlus Diagnostics LTD
  • Akers Biosciences Inc
  • Akonni Biosystems Inc
  • Alere Inc
  • Analytical Diagnostic Solutions Inc
  • ApoCell Inc
  • Aptatek BioSciences Inc
  • Atonomics A/S
  • BBB Technologies Inc
  • Beckman Coulter Inc
  • Binghampton University
  • Bio-AMD Inc
  • BioMedomics Inc
  • Biopico Systems Inc
  • Biosan Medical Ltd.
  • Biosensia Ltd
  • BioSIMS
  • Boston University
  • BreviTest Technologies LLC
  • Brigham and Women's Hospital
  • Calmark Sweden AB
  • Canon USA Inc
  • CardioGenics Inc
  • Center for Innovation in Point-of-Care Technologies for HIV/AIDS
  • Cepheid
  • ChipCare Corp
  • City, University of London
  • Clearbridge BioLoc Pte Ltd
  • Co-Diagnostics Inc
  • Corgenix Medical Corp
  • Cornell University
  • Cutting Edge Medical Devices Limited
  • Diagnostics For All Inc
  • DiaSorin SpA
  • Drew Scientific Co Ltd
  • Duke University
  • Dyamed Biotech Pte Ltd
  • EKF Diagnostics Holdings Plc
  • Endeavor Sciences Inc
  • Euroimmun AG
  • ExcitePCR Corp
  • Exosome Diagnostics Inc
  • Fawkes Biotechnology LLC
  • Firalis SAS
  • First Light Diagnostics Inc
  • Florida International University
  • Future Diagnostics Solutions BV
  • Genevo Biosystems Pte Ltd
  • Giner Inc
  • GlucoSentient Inc
  • Great Basin Scientific Inc.
  • HeatFlow Technologies Inc
  • Indian Institute of Science
  • Indian Institute of Technology Chennai
  • Johnson & Johnson
  • Lucendi Inc
  • Lucerna Inc
  • Magellan Diagnostics Inc
  • Masaryk University
  • Maxygen-mobile DNA tests
  • mBio Diagnostics Inc
  • McKesson Corp
  • MedNostic Technologies, LLC
  • Memorial Sloan Kettering Cancer Center
  • Merck Millipore Corp
  • Meridian Bioscience Inc
  • MML Ltd
  • Molecular Warehouse Ltd
  • Nalia Systems Ltd
  • NanoLab Inc
  • Newcastle University
  • Nikkiso Co Ltd
  • Ohmx Corp
  • OncoGenesis
  • OncoTherapy Science Inc
  • Ontera Inc
  • Ortho-Clinical Diagnostics Inc
  • Pacific Nanoscience, Inc.
  • POC Medical Systems Inc
  • Polymedco CDP, LLC
  • ProciseDx LLC
  • Protomex Life Sciences
  • Quanterix Corp
  • Qvella Corp
  • Radisens Diagnostics Ltd
  • Rapid Diagnostek, Inc.
  • RMIT University
  • Sebia SA
  • SeLux Diagnostics Inc
  • SenGenix Inc
  • Spectradyne LLC
  • StemTek Therapeutics SL
  • SynderBio Inc
  • Tecan Group Ltd
  • The Palo Alto Research Center
  • Thermal Gradient Inc
  • Trinity Biotech Plc
  • Tyncbest Biotechnology
  • University of Calgary
  • University of California Berkeley
  • University of Glasgow
  • University of Illinois at Chicago
  • University of Illinois at Urbana-Champaign
  • University of Michigan Pediatric Device Consortium
  • University of Pittsburgh
  • University of South Florida
  • University of Southern California
  • Virogenomics BioDevelopment Inc
  • Wellstat Diagnostics LLC
  • Xanthostat Diagnostics Inc
  • Yunnan Energy International Co Ltd

For more information about this report visit https://www.researchandmarkets.com/r/z6pgbq

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900